This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arexis Ab. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Sureshkumar Choudhary: Innovator in Recombinant Protein Manufacturing
Introduction
Sureshkumar Choudhary is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the manufacturing of recombinant proteins. His innovative approach has led to the development of a unique method for producing vials that contain these valuable compositions.
Latest Patents
Sureshkumar Choudhary holds a patent for a manufacturing method that is directed towards producing vials containing a composition comprising a recombinant protein. The patent outlines a process that includes several key steps: providing a container with the recombinant protein composition, applying a vacuum to degas the composition, and subsequently filling vials with the degassed product. This method enhances the quality and stability of the recombinant proteins, making it a valuable advancement in the field.
Career Highlights
Throughout his career, Sureshkumar has worked with prominent companies such as Arexis AB and MedImmune Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking projects in biotechnology. His work has not only advanced the manufacturing processes but has also had a positive impact on the development of therapeutic proteins.
Collaborations
Sureshkumar has collaborated with talented professionals in his field, including Mary Houchin and Marjo Peters. These collaborations have fostered an environment of innovation and have led to the successful development of new methodologies in protein manufacturing.
Conclusion
Sureshkumar Choudhary is a distinguished inventor whose work in recombinant protein manufacturing has made a significant impact in biotechnology. His patented methods and collaborations with industry professionals highlight his commitment to advancing the field. His contributions continue to pave the way for future innovations in the production of therapeutic proteins.